225 related articles for article (PubMed ID: 3528710)
1. [Autoantibodies in vitiligo. Clinical significance].
Morgan M; Castells A; Ramírez A
Med Cutan Ibero Lat Am; 1986; 14(2):139-42. PubMed ID: 3528710
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune vitiligo: detection of antibodies to melanin-producing cells.
Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI
N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108
[TBL] [Abstract][Full Text] [Related]
3. Complement-fixing activity to melanin-producing cells preceding the onset of vitiligo in a patient with type 1 polyglandular failure.
Betterle C; Caretto A; Pedini B; Rigon F; Bertoli P; Peserico A
Arch Dermatol; 1992 Jan; 128(1):123-4. PubMed ID: 1739282
[No Abstract] [Full Text] [Related]
4. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
[TBL] [Abstract][Full Text] [Related]
5. Anti-thyroid peroxidase antibody and vitiligo: a controlled study.
Daneshpazhooh M; Mostofizadeh G M; Behjati J; Akhyani M; Robati RM
BMC Dermatol; 2006 Mar; 6():3. PubMed ID: 16526964
[TBL] [Abstract][Full Text] [Related]
6. [Melanocyte antibodies in idiopathic vitiligo (author's transl)].
Höfs T; Zugehör M; Morenz J
Dermatol Monatsschr; 1981 Nov; 167(11):685-92. PubMed ID: 7044847
[No Abstract] [Full Text] [Related]
7. Vitiligo and polyglandular autoimmune disease with autoantibodies to melanin-producing cells. A new syndrome?
Peserico A; Rigon F; Semenzato G; Caretto A; Pasini CV; Betterle C
Arch Dermatol; 1981 Nov; 117(11):751-2. PubMed ID: 7316541
[No Abstract] [Full Text] [Related]
8. Apoptosis of melanocytes in vitiligo results from antibody penetration.
Ruiz-Argüelles A; Brito GJ; Reyes-Izquierdo P; Pérez-Romano B; Sánchez-Sosa S
J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
Kemp EH; Gavalas NG; Gawkrodger DJ; Weetman AP
Autoimmun Rev; 2007 Jan; 6(3):138-42. PubMed ID: 17289548
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis.
Howanitz N; Nordlund JL; Lerner AB; Bystryn JC
Arch Dermatol; 1981 Nov; 117(11):705-8. PubMed ID: 7316530
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the immune system in 55 Iranian patients with vitiligo.
Farrokhi S; Hojjat-Farsangi M; Noohpisheh MK; Tahmasbi R; Rezaei N
J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):706-11. PubMed ID: 16268875
[TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo.
al Badri AM; Foulis AK; Todd PM; Gariouch JJ; Gudgeon JE; Stewart DG; Gracie JA; Goudie RB
J Pathol; 1993 Feb; 169(2):203-6. PubMed ID: 8095298
[TBL] [Abstract][Full Text] [Related]
13. [Symptomatic tapetoretinal degeneration in pigment disorders of the skin: approaches to understanding the pathomechanism and therapy].
Krastel H; Anton-Lamprecht I; Alexandridis E; Tilgen W
Fortschr Ophthalmol; 1985; 82(6):562-70. PubMed ID: 4093108
[No Abstract] [Full Text] [Related]
14. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
Presser HJ; Morenz J; Höfs T; Zugehör M; Kühne KH; Brödemann M
Dermatol Monatsschr; 1987; 173(8):441-5. PubMed ID: 3311840
[No Abstract] [Full Text] [Related]
15. Autoimmunity as an aetiological factor in vitiligo.
Rezaei N; Gavalas NG; Weetman AP; Kemp EH
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study.
Korkij W; Soltani K; Simjee S; Marcincin PG; Chuang TY
J Cutan Pathol; 1984 Dec; 11(6):522-30. PubMed ID: 6520261
[TBL] [Abstract][Full Text] [Related]
17. Vitiligo and antibodies to melanocytes.
Bystryn JC; Pfeffer S
Prog Clin Biol Res; 1988; 256():195-206. PubMed ID: 3285350
[TBL] [Abstract][Full Text] [Related]
18. Immune mechanisms in vitiligo.
Bystryn JC
Immunol Ser; 1989; 46():447-73. PubMed ID: 2488866
[TBL] [Abstract][Full Text] [Related]
19. Immune-mediated subepithelial blistering diseases of the mucous membranes. Improving the detection of circulating autoantibodies by the use of concentrated serum samples.
Korman NJ; Watson RD
Arch Dermatol; 1996 Oct; 132(10):1194-8. PubMed ID: 8859030
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity and multiple endocrine abnormalities.
Forcier RJ; McIntyre OR; Frey WG; Andrada JA; Streiff RR
Arch Intern Med; 1972 Apr; 129(4):638-41. PubMed ID: 5067225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
